Across visits, we found statistically significant differences in fatigue and depression scores, as well as in haematological and iron parameters, all in favour of intravenous iron. The difference in physical fatigue score was -0♹7 (95% CI: -1♶5 -0♲8, P = 0♰06) in favour of intravenous iron, but did not meet the predefined difference of 1♸. Primary outcome was the aggregated change in physical fatigue score from baseline to 12 weeks postpartum. Participants received intravenous iron (n = 97) or oral iron (n = 99), and completed the Multidimensional Fatigue Inventory and Edinburgh Postnatal Depression Scale, and haematological and iron parameters were measured. Single-centre, open-label, randomized controlled trial. To evaluate the clinical efficacy of a single-dose intravenous infusion of iron isomaltoside compared with current treatment practice with oral iron measured by physical fatigue in women after postpartum haemorrhage.
0 kommentar(er)
